These data indicated that DUXAP8 could function as a scaffold by binding to EZH2 and LSD1, thus epigenetically silencing CDKN1A and KLF2 in pancreatic cancer cells. This evidence concerns the gene DUXAP8 and familial pancreatic carcinoma.